An inquiry into the molecular basis of HSV latency and reactivation
B Roizman, RJ Whitley - Annual review of microbiology, 2013 - annualreviews.org
Herpes simplex virus (HSV) evolved an elegant strategy that enables the virus to impact a
large fraction of the human population. The virus replicates at the portal of entry (mouth …
large fraction of the human population. The virus replicates at the portal of entry (mouth …
The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies
Background Cost-effectiveness studies inform resource allocation, strategy, and policy
development. However, due to their complexity, dependence on assumptions made, and …
development. However, due to their complexity, dependence on assumptions made, and …
An empiric risk scoring tool for identifying high-risk heterosexual HIV-1–serodiscordant couples for targeted HIV-1 prevention
EM Kahle, JP Hughes, JR Lingappa… - JAIDS Journal of …, 2013 - journals.lww.com
Methods: Using data from 3 prospective studies of HIV-1–serodiscordant couples from 7
African countries and standard methods for development of clinical prediction rules, the …
African countries and standard methods for development of clinical prediction rules, the …
Disclosure, knowledge of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya, and Namibia
P Bachanas, A Medley, S Pals, D Kidder… - AIDS patient care and …, 2013 - liebertpub.com
We describe the frequency of and factors associated with disclosure, knowledge of partner's
HIV status, and consistent condom use among 3538 HIV-positive patients attending …
HIV status, and consistent condom use among 3538 HIV-positive patients attending …
HIV testing and counseling leads to immediate consistent condom use among South African stable HIV-discordant couples
NE Rosenberg, AE Pettifor, G De Bruyn… - JAIDS Journal of …, 2013 - journals.lww.com
Objective: Effective behavioral HIV prevention is needed for stable HIV-discordant couples
at risk for HIV, especially those without access to biomedical prevention. This analysis …
at risk for HIV, especially those without access to biomedical prevention. This analysis …
Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial
A Mujugira, AS Magaret, C Celum… - The Journal of …, 2013 - academic.oup.com
Background. Daily suppressive therapy with valacyclovir reduces risk of sexual transmission
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by …
Hormonal contraceptive use and risk of HIV-1 disease progression
Background: For HIV-1-infected women, hormonal contraception prevents unintended
pregnancy, excess maternal morbidity, and vertical HIV-1 transmission. Hormonal …
pregnancy, excess maternal morbidity, and vertical HIV-1 transmission. Hormonal …
The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda
Abstract Background The Fogarty International Center (FIC) has supported research
capacity development for over twenty years. While the mission of FIC is supporting and …
capacity development for over twenty years. While the mission of FIC is supporting and …
Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters
JR Lingappa, KK Thomas, JP Hughes… - AIDS research and …, 2013 - liebertpub.com
Plasma HIV-1 RNA set point is an important predictor of HIV-1 disease progression. We
hypothesized that inoculum size and HIV-1 exposure prior to HIV-1 transmission may …
hypothesized that inoculum size and HIV-1 exposure prior to HIV-1 transmission may …
Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy
SA Fiscus, S Cu-Uvin, AT Eshete… - Clinical infectious …, 2013 - academic.oup.com
Background. Combination antiretroviral therapy (cART) reduces genital tract human
immunodeficiency virus type 1 (HIV-1) load and reduces the risk of sexual transmission, but …
immunodeficiency virus type 1 (HIV-1) load and reduces the risk of sexual transmission, but …